Key points from article :
Johnson & Johnson's medical technology division has received FDA clearance for its first robotic-assisted spine surgery platform, Velys Spine. This system is designed to revolutionize spinal fusion procedures by offering "active robotic assistance" that adapts to both patient movements and surgeon preferences.
Developed in partnership with eCential Robotics, Velys Spine stands out from traditional fixed-arm robotic systems by actively tracking and adjusting to changes in the spine's position throughout the operation. This ensures greater precision and safety during complex procedures.
The Velys Spine system seamlessly integrates with DePuy Synthes' existing spinal implants and instruments, including the recently cleared TriALTIS portfolio. This compatibility allows surgeons to leverage their familiarity with these tools while benefiting from the enhanced capabilities of robotic assistance. The FDA clearance builds upon a previous approval for Velys' knee-focused platform in June, expanding its applications to partial knee replacements.
While Johnson & Johnson is gearing up for the commercial launch of Velys Spine in the first half of 2024, it faces competition from Stryker, another major player in the medical technology field.
Stryker is also preparing to launch its own spine surgery system later this year, intensifying the race to bring cutting-edge robotic solutions to the operating room. With advancements like Velys Spine, the future of spine surgery is poised for greater precision, safety, and efficiency.
